Sale of Securities

CRISPR Therapeutics AG Filed 2023-05-30 Acc 0001950047-23-001028

Documents 1

2024-01-16 144 Sale of Securities
2023-06-01 4 Chief Executive Officer sold 25,000 shares at an average $64.88 ($1,621,894)
2023-05-30 144 Sale of Securities
2023-05-25 4 Chief Medical Officer gave up 2,527 shares (to pay taxes)
2023-05-10 144 Sale of Securities

Paste a passage to link it

At least 12 characters, not counting spaces, so the link points to one passage.

Loading xsl144X01/primary_doc.xml…

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…